"Ann Intern Med"[journal] 检索结果

181. Introducing I.M. Matters News.

作者: Christine Laine.;Jennifer Kearney-Strouse.
来源: Ann Intern Med. 2026年179卷1期IMN1页

182. In provoked VTE with ≥1 enduring risk factor, extending anticoagulation with apixaban reduced symptomatic recurrent VTE at 12 mo.

作者: Andrew Dunn.; .
来源: Ann Intern Med. 2026年179卷1期JC10页

GIM/FP/GP: [Formula: see text] Hematology: [Formula: see text].

183. Q&A: Past challenges prop up today's politics around gender-affirming care.

作者: Ryan DuBosar.
来源: Ann Intern Med. 2026年179卷2期IMN12-IMN14页

184. In older adults, RSV prefusion F vaccine reduced hospitalization for RSV-related respiratory tract disease vs. no vaccine.

作者: Henry S Sacks.; .
来源: Ann Intern Med. 2026年179卷1期JC4页

GIM/FP/GP: [Formula: see text] Geriatrics: [Formula: see text] Infectious Disease: [Formula: see text] Pulmonology: [Formula: see text].

185. In hypercholesterolemia, adding inclisiran to individually optimized lipid-lowering therapy improved LDL-C levels at 90 d.

作者: Tess Allan.;L Kristin Newby.; .
来源: Ann Intern Med. 2026年179卷1期JC9页

GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text].

186. Fight misinformation by acknowledging fears, building trust.

作者: Stacey Butterfield.
来源: Ann Intern Med. 2026年179卷2期IMN14-IMN16页

187. In older adults with impaired physical performance after MI, multidomain rehabilitation reduced CV death or CV hospitalization at 1 y.

作者: Ravishankar Ramaswamy.; .
来源: Ann Intern Med. 2026年179卷1期JC5页

GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text] Geriatrics: [Formula: see text].

188. 2025 brought a bounty of sepsis research.

作者: Stacey Butterfield.
来源: Ann Intern Med. 2026年179卷2期IMN9-IMN11页

189. Effectiveness and Safety of Statins in Type 2 Diabetes According to Baseline Cardiovascular Risk : A Target Trial Emulation Study.

作者: Vincent Ka Chun Yan.;Joseph Edgar Blais.;John-Michael Gamble.;Esther Wai Yin Chan.;Ian Chi Kei Wong.;Eric Yuk Fai Wan.
来源: Ann Intern Med. 2026年179卷2期157-167页

Whether statins benefit patients with type 2 diabetes mellitus (T2DM) with low predicted 10-year cardiovascular risk is uncertain.

190. 2025 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline for the Primary Care Management of Chronic Kidney Disease.

作者: Amy R Schwartz.;Jonathan Sosnov.;Jonathan Brown.;Cynthia Delgado.;Linda Fried.;Manjula Kurella Tamura.;John W Morrison.;Sankar D Navaneethan.;Paul M Palevsky.;Diane Rybacki.;James Sall.;Sunil Verma.;Maura Watson.;Jesse Wickham.;Mai Nguyen.
来源: Ann Intern Med. 2026年179卷3期411-424页

Management of chronic kidney disease (CKD) has been rapidly evolving, now involving many interventions that can be managed in the primary care setting. In April 2025, leadership within the U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) approved a joint clinical practice guideline (CPG) for the primary care management of CKD. This synopsis reviews the 2025 recommendations related to diagnosis, assessment, and management of CKD.

191. The Pharmaceutical Industry's Quiet Win in the One Big Beautiful Bill Act.

作者: Shria Bucha.;Matthew J Martin.;William B Feldman.
来源: Ann Intern Med. 2026年179卷3期440-441页

192. Management of Conflicts of Interest in Practice Guidelines: Time to Also Account for Open-Mindedness?

作者: Elie A Akl.;Zachary Munn.;Joanne Khabsa.
来源: Ann Intern Med. 2026年179卷1期132-133页

193. Once-Weekly Oral Islatravir Plus Lenacapavir Versus Daily Oral Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Persons With HIV-1 : A Phase 2 Randomized Study.

作者: Amy E Colson.;Gordon E Crofoot.;Peter J Ruane.;Moti N Ramgopal.;Alexandra W Dretler.;Ronald G Nahass.;Gary I Sinclair.;Mezgebe Berhe.;Afsoon Roberts.;Shauna Applin.;Cynthia Brinson.;Dushyantha Jayaweera.;Kimberly A Workowski.;Fadi Shihadeh.;Shan-Yu Liu.;Stephanie Klopfer.;Cyril Llamoso.;Sharline Madera.;Hadas Dvory-Sobol.;Martin S Rhee.;Elizabeth G Rhee.;Jared M Baeten.;Joseph J Eron.
来源: Ann Intern Med. 2026年179卷2期168-176页

Once-weekly oral islatravir plus lenacapavir (ISL+LEN) has the potential to address adherence challenges with daily HIV-1 treatment.

194. The Enemy.

作者: Michael Bretthauer.
来源: Ann Intern Med. 2026年179卷2期296-297页

195. Web Exclusive. Annals Graphic Medicine - "Well, I Did My Own Research…".

作者: Peter Sherman.
来源: Ann Intern Med. 2026年179卷1期e2504697GM页

196. Summary for Patients: Cannabis-Based Products for Chronic Pain.

来源: Ann Intern Med. 2026年179卷2期I22页

197. Defining the Safety and Efficacy of Cannabis for Chronic Pain: Novel Approaches and Reframing Objectives.

作者: Ziva D Cooper.
来源: Ann Intern Med. 2026年179卷2期305-306页

198. Annals Video Summary - Cannabis-Based Products for Chronic Pain.

来源: Ann Intern Med. 2026年179卷2期e2504735VS页

199. Cannabis-Based Products for Chronic Pain : An Updated Systematic Review.

作者: Roger Chou.;Rongwei Fu.;Azrah Y Ahmed.;Benjamin J Morasco.
来源: Ann Intern Med. 2026年179卷2期230-241页

Benefits and harms of cannabinoids for chronic pain are uncertain.

200. Advancing Physical Function Outcomes in Glucagon-Like Peptide-1 Receptor Agonist Trials.

作者: Jan H M Karregat.;Stuart Phillips.;Maria T E Hopman.;Thijs M H Eijsvogels.;Tim Kambič.
来源: Ann Intern Med. 2026年179卷2期298-300页

结果排序

文献格式

出版时间

出版类型

出版语言